(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHAGERIARUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHAGERIARUS

ST13

US500000090667892

Class

42

Filing

90667892

Registration

7172143

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

09/26/2023

Trademark type

Word

Nice classes

42

Filing date

04/23/2021

Registration date

09/26/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/26/2023

Last transaction

09/26/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Sungnam-si,Kyeonggi-do, KR

Examiner

ANKRAH, NAAKWAMA

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

iNtRON Biotechnology, Inc.

Representatives

Lawrence K. Nodine BALLARD SPAHR LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development relating to drug substance and drug products for the pharmaceuticalbiotech and vaccine sectors; evaluation relating to drug substance and drug products for the pharmaceuticalbiotech and vaccine sectors; consultancy relating to drug substance and drug products for the pharmaceuticalbiotech and vaccine sectors; testing relating to drug substance and drug products for the pharmaceuticalbiotech and vaccine sectors; research and development of pharmaceuticalbiotech and vaccine products; consultancy relating to pharmaceuticalbiotech and vaccine sectors; advisory services relating to research and development of pharmaceuticalbiotech and vaccine products

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/26/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

09/26/2023

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

08/22/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/22/2023

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/21/2023

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

07/21/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/18/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/23/2023

PUBO

PUBLISHED FOR OPPOSITION

05/23/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/15/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/14/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/14/2023

ALIE

ASSIGNED TO LIE

04/13/2023

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/18/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/04/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/04/2022

CNSI

SUSPENSION INQUIRY WRITTEN

08/04/2022

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/08/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/21/2021

GNSL

LETTER OF SUSPENSION E-MAILED

12/21/2021

CNSL

SUSPENSION LETTER WRITTEN

12/21/2021

DOCK

ASSIGNED TO EXAMINER

12/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2021

NWAP

NEW APPLICATION ENTERED

04/27/2021

Continuous trademark protection

Get notified about every new filing that threatens PHAGERIARUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.